CD19/CD20 Double Knockout Raji Cell Line
82623
Product group (Cell) Culture
Overview
- SupplierBPS Bioscience
- Product NameCD19/CD20 Double Knockout Raji Cell Line
- Delivery Days Customer7
- CertificationResearch Use Only
- Scientific DescriptionCD19/CD20 Double Knockout Raji Cell Line is a Raji cell line where CD19 (Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) and CD20 (B-lymphocyte antigen CD20, or MS4A1) have been genetically removed from Raji cells using CRISPR/Cas9 genome editing. This cell line has been validated by genome sequencing and flow cytometry.
- UNSPSC41116155